Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Pepperl+Fuchs GB Limited

Pepperl+Fuchs is a leading developer and manufacturer of electronic sensors and components for the global automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success, since more than 60 years. Pepperl+Fuchs employs 5,200 people worldwide and has manufacturing facilities in Germany, USA, Singapore, Hungary, Indonesia and Vietnam, most of them ISO 9001 certified.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Pepperl+Fuchs GB Limited
77 Ripponden Road, Oldham, Lancashire, OL1 4EL, United Kingdom
+44 (0)161 6336431
Contact Pepperl+Fuchs GB Limited
Website

 Latest Content from PMHub 

Showcasing our multichannel capabilities in Berlin

White Papers and Resources | September 22, 2016 | Anthill Agency

Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications

DAM and CMS: managing assets to maximise adoption and value

White Papers and Resources | September 19, 2016 | Blue Latitude Health

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised...

Tenth Lucid Academy module delivered – nurturing talent and driving excellence

Press Releases | September 15, 2016 | Lucid Group Communications Limited

Celebrating the success of the Lucid Academy

Lucid launch new recruitment campaign to attract top talent in medical writing

Press Releases | September 8, 2016 | Lucid Group Communications Limited

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Press Releases | September 7, 2016 | Lucid Group Communications Limited

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

How to enable each healthcare professional to fully understand your product

White Papers and Resources | September 7, 2016 | Anthill Agency

Read these three articles to understand how working at an individual level benefits all customers:

Alzheimer’s disease: reviewing the immediate treatment horizon

White Papers and Resources | September 1, 2016 | Blue Latitude Health

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

A stumble, but not a fall – what’s next for Opdivo?

White Papers and Resources | August 25, 2016 | Blue Latitude Health

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.

Meet Anthill at conferences in London

White Papers and Resources | August 19, 2016 | Anthill Agency

October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit

Immuno-oncology; bringing patients closer to treatment

White Papers and Resources | August 18, 2016 | Blue Latitude Health

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?